Clinical Trials Browser

balixafortide × Clear all

Breast Neoplasms

NCT04826016 2023-03-20

POLTER

Phase 1/2 Withdrawn

Breast

Advanced Breast Cancer

NCT01837095 2018-09-14

Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer

Phase 1 Completed

54 enrolled

Breast

Breast Neoplasms

NCT01413568 2016-02-26

Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies

Phase 1/2 Completed

38 enrolled

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01105403 2014-04-23

Exploratory Study on POL6326 in Stem Cell Mobilization

Phase 2 Completed

21 enrolled

Plasma cell

Multiple Myeloma

Clinical Trials

FORTRESS

POLTER

Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer

Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies

Exploratory Study on POL6326 in Stem Cell Mobilization